MedShift, a leading medical technology company, announced today it has completed a $108 million capital raise from Turning Rock Partners, Micota Capital, and OY6 Capital. The compilation facility solidifies MedShift's industry value and propels advancements across the company's three primary technologies: Specialty Device Subscription, Connected Medical Device (IoT), and the Velocity Technology Suite (Enterprise Software as a Service).
"The continued validation of MedShift's holistic market offerings is very exciting to witness," stated Brian Phillips, Executive Chairman and Co-Founder of MedShift. "Continued profitable growth was a catalyst to securing this raise, and the entire team executed flawlessly through wildly shifting market conditions to successfully complete the transaction. I look forward to the accelerated delivery of cutting-edge solutions to industry and practitioner partners this facility will support."
MedShift has been at the forefront of developing technology solutions that serve a broad range of medical device manufacturers and practitioners across the Dermatology, Gynecology, Plastic Surgery, and MedSpa market. The company's value proposition is unique in that it combines its expertise in designing, deploying, and maintaining innovative technology solutions for medical device manufacturers, with a range of complementary products and services.
"We are excited about the future of MedShift and the impact we can make on the healthcare industry," said Joe Gasque, Chief Executive Officer of MedShift. "With MedShift, we aim to enrich aesthetic medical device manufacturers with high-quality, high-performing solutions that have the power to transform their business operations and help them achieve their goals. This additional funding will allow us to work towards fulfilling a significant unmet need."
About MedShift
MedShift, a medical technology company founded in 2015 and headquartered in Charlotte, NC, is an emerging leader in the healthcare industry. MedShift is one of the largest and fastest growing solution providers to the aesthetic industry and is differentiated by its technology and software as a service focus. The company brings opportunities to drive growth and scale to medical device manufacturers as well as individual medical providers across various markets, including Dermatology, Gynecology, Plastic Surgery, and MedSpa. MedShift's business is centered around three technology divisions, Specialty Device Subscription, Connected Medical Device (IoT), and the Velocity Technology Suite (Enterprise Software as a Service), and a range of complementary products and services that streamline the complex supply-and-demand landscape of device consumables and injectables. MedShift's mission is to drive business transformation and power sales through the use of modern technology. The company currently has partnered with 25 aesthetic manufacturers and distributors, a portfolio of 80+ devices and over 2,000 active medical providers.
